Ike Swetlitz's profile photo

Ike Swetlitz

Boston

Health Reporter at Bloomberg News

I don't check DM's; contact me here: https://t.co/M1WW3rdoWC Bloomberg @business health reporter in Boston. Previously: @SearchlightNM @statnews

Featured in: Favicon bloomberg.com Favicon msn.com Favicon theguardian.com Favicon businessinsider.com Favicon foxnews.com Favicon huffpost.com Favicon time.com Favicon latimes.com Favicon pbs.org Favicon sfgate.com

Articles

  • 1 week ago | news.bloomberglaw.com | Ike Swetlitz |John Tozzi |Tanaz Meghjani

    UnitedHealth Group Inc. is cutting commissions for brokers on some Medicare Advantage plans, according to documents reviewed by Bloomberg News, a move that appears designed to discourage agents from selling those plans. The decision comes as UnitedHealth grapples with high costs in Medicare Advantage that derailed its financial outlook and sent its share price tumbling. By steering brokers away from selling some of these plans, the insurance giant could ultimately lower its costs.

  • 1 week ago | news.bloombergtax.com | Ike Swetlitz |John Tozzi

    UnitedHealth Group Inc. is cutting commissions for brokers on some Medicare Advantage plans, according to documents reviewed by Bloomberg News, a move that appears designed to discourage agents from selling those plans. The decision comes as UnitedHealth grapples with high costs in Medicare Advantage that derailed its financial outlook and sent its share price tumbling. By steering brokers away from selling some of these plans, the insurance giant could ultimately lower its costs.

  • 1 week ago | bloomberg.com | Ike Swetlitz |John Tozzi |Tanaz Meghjani

    (Bloomberg) -- UnitedHealth Group Inc. is cutting commissions for brokers on some Medicare Advantage plans, according to documents reviewed by Bloomberg News, a move that appears designed to discourage agents from selling those plans. The decision comes as UnitedHealth grapples with high costs in Medicare Advantage that derailed its financial outlook and sent its share price tumbling. By steering brokers away from selling some of these plans, the insurance giant could ultimately lower its costs.

  • 1 week ago | japantimes.co.jp | Ike Swetlitz

    Elon Musk’s Neuralink used a brain implant to enable a monkey to see something that wasn’t physically there, according to an engineer, as it moves toward its goal of helping blind people see. The device, called Blindsight, stimulated areas of a monkey’s brain associated with vision, Neuralink engineer Joseph O’Doherty said Friday at a conference. At least two-thirds of the time, the monkey moved its eyes toward something researchers were trying to trick the brain into visualizing.

  • 1 week ago | thestar.com.my | Ike Swetlitz

    Elon Musk’s Neuralink Corp used a brain implant to enable a monkey to see something that wasn’t physically there, according to an engineer, as it moves toward its goal of helping blind people see. The device, called Blindsight, stimulated areas of a monkey’s brain associated with vision, Neuralink engineer Joseph O’Doherty said last Friday at a conference. At least two-thirds of the time, the monkey moved its eyes toward something researchers were trying to trick the brain into visualising.

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

X (formerly Twitter)

Followers
3K
Tweets
3K
DMs Open
Yes
Ike Swetlitz
Ike Swetlitz @ikeswetlitz
10 Jun 25

Crypto billionaire @FEhrsam hired at least 8 people from @elonmusk's @neuralink for his new brain-tech startup @nudge, trying to build a headset that will treat diseases, improve your mood, help you sleep. What's he up to? w/@bizcarson for @business: https://t.co/C9OnEYxGIZ

Ike Swetlitz
Ike Swetlitz @ikeswetlitz
12 Sep 24

Major US health insurer Anthem is demanding at least $1 million from health care providers for allegedly improper Ozempic prescriptions. Prescribers deny the allegations, and experts are scratching their heads at Anthem's behavior. Mine for @business: https://t.co/RSJSA8FCDa

Ike Swetlitz
Ike Swetlitz @ikeswetlitz
14 Aug 24

News: @EliLillyandCo sent cease-and-desist letters demanding doctors stop selling and promoting compounded versions of Mounjaro and Zepbound made at state-licensed facilities. My story with @g0ingmad for @business: https://t.co/TSdyjuOkNs